Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Beyer

Showing results (111-120 of 225) with videos related to

Pageof 23
Sort By:
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 21, 2020
Rivaroxaban Versus Warfarin for Management of Obese African Americans With Non-Valvular Atrial Fibrillation or Venous Thromboembolism: A Retrospective Cohort AnalysisOlivia S Costa, Jan Beyer-Westendorf, Veronica Ashton, et al.
Journal of Thrombosis and Thrombolysis|June 27, 2020
Effectiveness and safety of rivaroxaban versus warfarin in obese patients with acute venous thromboembolism: analysis of electronic health record dataOlivia S Costa, Jan Beyer-Westendorf, Veronica Ashton, et al.
The Lancet. Haematology|February 22, 2017
Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trialJan Beyer-Westendorf, Sebastian M Schellong, Horst Gerlach, et al.
Current Medical Research and Opinion|April 30, 2020
Effectiveness and safety of rivaroxaban versus warfarin in obese nonvalvular atrial fibrillation patients: analysis of electronic health record dataOlivia S Costa, Jan Beyer-Westendorf, Veronica Ashton, et al.
The Lancet. Haematology|June 7, 2017
Evaluation of direct oral anticoagulants in superficial-vein thrombosis - Authors' replyJan Beyer-Westendorf, Sebastian M Schellong, Horst Gerlach, et al.
Thrombosis and Haemostasis|November 10, 2019
Accuracy of a Rapid Diagnostic Test for the Presence of Direct Oral Factor Xa or Thrombin Inhibitors in Urine-A Multicenter TrialJob Harenberg, Jan Beyer-Westendorf, Mark Crowther, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|October 1, 2021
Detection of Direct Oral Anticoagulants in Patient Urine Samples by Prototype and Commercial Test Strips for DOACs - A Systematic Review and Meta-analysisAndrea Martini, Job Harenberg, Rupert Bauersachs, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|July 10, 2023
Management of major bleeding for anticoagulated patients in the Emergency Department: an European experts consensus statementBarbra Backus, Jan Beyer-Westendorf, Rick Body, et al.
Diabetes, Obesity & Metabolism|May 18, 2019
Effectiveness and safety of rivaroxaban and warfarin for prevention of major adverse cardiovascular or limb events in patients with non-valvular atrial fibrillation and type 2 diabetesWilliam L Baker, Jan Beyer-Westendorf, Thomas J Bunz, et al.
Scientific Reports|May 28, 2026
Effects of pneumatic tube systems on next-generation viscoelastic coagulation test devices in septic patients and healthy individuals: Results of the randomized controlled VETaPT trialMartin Mirus, Erik Buehrer, Oliver Tiebel, et al.
Pageof 23

Showing results (111-120 of 225) with videos related to

Sort By:
Pageof 23
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 21, 2020
Rivaroxaban Versus Warfarin for Management of Obese African Americans With Non-Valvular Atrial Fibrillation or Venous Thromboembolism: A Retrospective Cohort AnalysisOlivia S Costa, Jan Beyer-Westendorf, Veronica Ashton, et al.
Journal of Thrombosis and Thrombolysis|June 27, 2020
Effectiveness and safety of rivaroxaban versus warfarin in obese patients with acute venous thromboembolism: analysis of electronic health record dataOlivia S Costa, Jan Beyer-Westendorf, Veronica Ashton, et al.
The Lancet. Haematology|February 22, 2017
Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trialJan Beyer-Westendorf, Sebastian M Schellong, Horst Gerlach, et al.
Current Medical Research and Opinion|April 30, 2020
Effectiveness and safety of rivaroxaban versus warfarin in obese nonvalvular atrial fibrillation patients: analysis of electronic health record dataOlivia S Costa, Jan Beyer-Westendorf, Veronica Ashton, et al.
The Lancet. Haematology|June 7, 2017
Evaluation of direct oral anticoagulants in superficial-vein thrombosis - Authors' replyJan Beyer-Westendorf, Sebastian M Schellong, Horst Gerlach, et al.
Thrombosis and Haemostasis|November 10, 2019
Accuracy of a Rapid Diagnostic Test for the Presence of Direct Oral Factor Xa or Thrombin Inhibitors in Urine-A Multicenter TrialJob Harenberg, Jan Beyer-Westendorf, Mark Crowther, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|October 1, 2021
Detection of Direct Oral Anticoagulants in Patient Urine Samples by Prototype and Commercial Test Strips for DOACs - A Systematic Review and Meta-analysisAndrea Martini, Job Harenberg, Rupert Bauersachs, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|July 10, 2023
Management of major bleeding for anticoagulated patients in the Emergency Department: an European experts consensus statementBarbra Backus, Jan Beyer-Westendorf, Rick Body, et al.
Diabetes, Obesity & Metabolism|May 18, 2019
Effectiveness and safety of rivaroxaban and warfarin for prevention of major adverse cardiovascular or limb events in patients with non-valvular atrial fibrillation and type 2 diabetesWilliam L Baker, Jan Beyer-Westendorf, Thomas J Bunz, et al.
Scientific Reports|May 28, 2026
Effects of pneumatic tube systems on next-generation viscoelastic coagulation test devices in septic patients and healthy individuals: Results of the randomized controlled VETaPT trialMartin Mirus, Erik Buehrer, Oliver Tiebel, et al.
Pageof 23